Quipt Home Medical Corp., a U.S.-based provider of respiratory care equipment, has filed its definitive proxy statement and management information circular in preparation for a special shareholder meeting scheduled for March 3, 2026. The meeting will address a proposed plan of arrangement under which affiliates of Kingswood Capital Management and Forager Capital Management will acquire all outstanding shares of Quipt for $3.65 per share in cash. This offer represents a 54% premium over the company’s 30-day volume-weighted average price as of December 12, 2025.
The proxy materials have been made available on regulatory websites including SEDAR+, the SEC’s EDGAR system, and Quipt’s own website. Shareholders will soon receive these documents by mail to review ahead of the vote. Quipt has also received an interim court order related to the arrangement process.
**Why this matters**
This acquisition proposal offers Quipt shareholders a significant premium on their shares, potentially providing immediate value. The special meeting and related filings are key steps in the approval and completion of the transaction, which could lead to a change in ownership and strategic direction for Quipt Home Medical.
Source: NewsData